• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 5. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Steroidal glycosides Steroidal saponins
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Steroidal saponins

Introduction to Ophiopojaponin C (CAS No. 911819-08-4)

Ophiopojaponin C, a naturally occurring compound with the chemical designation CAS No. 911819-08-4, has garnered significant attention in the field of pharmaceutical research due to its unique structural properties and promising biological activities. This compound, isolated from the roots of Ophiopogon japonicus, a plant traditionally used in Eastern medicine, belongs to the saponin class of glycosides. The intricate molecular architecture of Ophiopojaponin C, characterized by its triterpene aglycone and sugar moieties, contributes to its diverse pharmacological potential.

Recent studies have highlighted the antimicrobial and anti-inflammatory properties of Ophiopojaponin C, making it a subject of intense investigation for potential therapeutic applications. Research indicates that this compound exerts its effects by modulating various cellular pathways, including those involved in immune response and oxidative stress regulation. The structural features of Ophiopojaponin C, particularly its hydroxylated and glycosidically linked regions, are believed to play a crucial role in its biological interactions.

In vitro and in vivo experiments have demonstrated that Ophiopojaponin C exhibits notable cytotoxicity against certain cancer cell lines, suggesting its potential as an anticancer agent. The mechanism of action appears to involve the induction of apoptosis and inhibition of cell proliferation, mechanisms that are currently under further exploration. Additionally, preliminary studies suggest that Ophiopojaponin C may possess neuroprotective properties, which could be relevant for the development of treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's.

The synthesis and structural elucidation of Ophiopojaponin C have been areas of active interest in synthetic chemistry. Researchers have developed sophisticated methodologies to produce this compound in a laboratory setting, enabling more extensive pharmacological testing. Advances in mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy have been instrumental in confirming the structural integrity of synthetic Ophiopojaponin C, ensuring that it mirrors the natural compound's configuration.

One of the most compelling aspects of Ophiopojaponin C is its potential for drug development due to its multifaceted biological activities. The compound's ability to interact with multiple targets within cellular systems makes it a promising candidate for combinatorial therapies. For instance, its anti-inflammatory effects could be synergistic when combined with traditional treatments for chronic inflammatory conditions. Furthermore, its antimicrobial properties may offer new strategies for combating drug-resistant bacterial infections.

The traditional use of Ophiopogon japonicus in herbal medicine has provided a rich foundation for modern pharmacological research. Ethnobotanical studies have long recognized the plant's therapeutic value, particularly for conditions related to inflammation and immune modulation. The isolation and characterization of compounds like Ophiopojaponin C bridge the gap between traditional knowledge and contemporary scientific inquiry, offering a novel perspective on natural product-based drug discovery.

As research on Ophiopojaponin C progresses, there is growing interest in understanding its pharmacokinetic profile and potential side effects. Preclinical studies are essential for determining dosing regimens and identifying any adverse reactions that might arise from prolonged exposure. These studies will also help elucidate how Ophiopojaponin C is metabolized within the body, providing insights into its bioavailability and duration of action.

The development of derivatives based on the structure of Ophiopojaponin C represents another exciting avenue for research. By modifying specific functional groups or introducing new chemical entities, scientists aim to enhance the compound's efficacy while minimizing potential toxicity. Such modifications could lead to novel therapeutic agents with improved pharmacological profiles suitable for clinical use.

The global interest in natural products as sources of bioactive compounds underscores the importance of continued research into species like Ophiopogon japonicus. The discovery of compounds such as Ophiopojaponin C not only expands our understanding of plant-derived pharmaceuticals but also offers hope for addressing unmet medical needs through innovative drug development strategies.

• 168009-87-8(b-D-Glucopyranoside, (1b,3b,25S)-3-hydroxyspirost-5-en-1-yl O-b-D-glucopyranosyl-(1(R)3)-O-6-deoxy-a-L-mannopyranosyl-(1(R)2)-O-[b-D-xylopyranosyl-(1(R)3)]-, 6-acetate (9CI))
• 182284-68-0(Lirioprolioside B)
• 1220707-33-4(2''-O-Acetylsprengerinin C)
• 65604-79-7(Ophiopogonin B')
• 1309084-25-0((25R)-26-O-beta-D-glucopyranosyl-5alpha-furostan-3beta,22alpha,26-triol 3-O-beta-D-glucopyranosyl-(1->6)-O-beta-D-glucopyranoside)
• 190781-46-5(b-D-Galactopyranoside, (1b,3b,12b,23S,24S,25R)-1-[(O-4-O-acetyl-6-deoxy-a-L-mannopyranosyl-(1®2)-O-[b-D-xylopyranosyl-(1®3)]-b-D-glucopyranosyl)oxy]-3,12,23-trihydroxyspirost-5-en-24-yl6-deoxy- (9CI))
• 130431-11-7((25S)-ruscogenin 1-O-2)>3)>-beta-D-fucopyranoside)
• 1486510-50-2(25(S)-ruscogenin 1-O-alpha-L-rhamnopyranosyl-(1?2)-[beta-D-xylopyranosyl-(1?3)]-4-O-acetyl-beta-D-fucopyranoside)
• 11054-24-3(b-D-Galactopyranoside, (1b,3b,25R)-3-hydroxyspirost-5-en-1-yl2-O-(3-O-acetyl-6-deoxy-a-L-mannopyranosyl)-6-deoxy-)
• 214056-88-9((1beta,3beta,23S,25R)-23-(beta-D-glucopyranosyloxy)-3-hydroxyspirost-5-en-1-yl beta-D-glucopyranosyl-(1->3)-6-deoxy-alpha-L-mannopyranosyl-(1->2)-3,4,6-tri-O-acetyl-beta-D-galactopyranoside)